Dual CDK4/6–PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcoma

Osteosarcoma (OS) in pediatric, adolescent, and young adult (AYA) patients is an aggressive bone cancer with limited treatment options. Dysregulation of the CDK4/6–cyclin D axis and the PI3K/mTOR pathway contributes to OS pathogenesis, providing a biological rationale for co-targeting these signalin...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Farinaz Barghi, M. Reza Saadatzadeh, Erika A. Dobrota, Harlan E. Shannon, Barbara J. Bailey, Courtney Young, Rada Malko, Ryli Justice, Niknam Riyahi, Christopher Davis, Khadijeh Bijangi-Vishehsaraei, Keiko Kreklau, Lauren K. Stevens, Jenna Koenig, Shirzat Sulayman, Sheng Liu, Jun Wan, Melissa A. Trowbridge, Kathy Coy, Felicia M. Kennedy, Anthony L. Sinn, Marissa Just, Kyle W. Jackson, George Sandusky, L. Daniel Wurtz, Christopher D. Collier, Dana Mitchell, Emily E. Seiden, Edward M. Greenfield, Emma Doud, Amber Mosley, Steven P. Angus, Michael J. Ferguson, Pankita H. Pandya, Karen E. Pollok
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2026-02-01
Reeks:	Neoplasia: An International Journal for Oncology Research
Onderwerpen:	Osteosarcoma CDK4/6 PI3K/mTOR Senescence Autophagy Preclinical models
Online toegang:	http://www.sciencedirect.com/science/article/pii/S1476558625001459
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!